The influence of orphenadrine or imipramine on the hypertensive response of physostigmine in the rat.
An intravenous infusion of orphenadrine or imipramine to artificially ventilated, urethane anaesthetized rats, completely blocked the physostigmine induced increase in blood pressure and the blood pressure increase induced by electrical stimulation of the posterior hypothalamus; effects mediated via the sympathetic nerve. The noradrenaline induced blood pressure increase was not changed during an infusion with orphenadrine but was markedly depressed during an infusion with imipramine. During an infusion with both orphenadrine or imipramine the pressor response induced by stimulation of the spinal cord were completely blocked in pithed rats. The pattern of the blockade was comparable with the blockade of the pressor response after hypothalamic stimulation. These results show that at least in rats both orphenadrine and imipramine prevents the central stimulatory sympathetic effects on the cardiovascular system by interfering with the sympathetic nervous system. The site of action is discussed.


CONCLUSIONS
the present results show that although physostigmine may be helpful in the treatment of central anticholinergic effects caused by overdoses of orphenadrine and imipramine it is of no use for combating the direct toxic effects of both drugs on the cardiovascular system.
D000818:Animals; D001794:Blood Pressure / Q000187:drug effects*; D004558:Electric Stimulation; D006339:Heart Rate / Q000187:drug effects; D007031:Hypothalamus / Q000502:physiology; D007099:Imipramine / Q000494:pharmacology* / Q000633:toxicity; D008297:Male; D009638:Norepinephrine / Q000494:pharmacology; D009966:Orphenadrine / Q000494:pharmacology* / Q000633:toxicity; D010830:Physostigmine / Q000494:pharmacology*; D051381:Rats; D011919:Rats, Inbred Strains; D013564:Sympathetic Nervous System / Q000187:drug effects
D010830:Physostigmine; D009966:Orphenadrine; D007099:Imipramine; D009638:Norepinephrine